2don MSN
First-of-its-kind drug aims to protect the heart while increasing effectiveness of cancer treatments
A team of University of Alberta researchers has developed a cardio-oncology drug that protects the heart from chemotherapy ...
2don MSN
High-precision human immune aging clock identifies RUNX1 as key target for T cell senescence
The immune system acts as a critical sentinel of organismal aging, integrating the sensing of physiological states with the ...
The technology reflects a broader shift across China's cosmetics sector, where companies are increasingly investing in ...
A recent study in the Chinese Medical Journal reveals that circulating exosomal miR-122-3p is significantly upregulated in patients with metabolic dysfunction-associated steatotic liver disease. It ...
A new law named after Charlie Kirk is encouraging Tennessee teachers to include the positive impacts of religion in American ...
Rather than representing a distinct gene product, this peptide arises from alternative splicing events within the IGF-1 gene locus, leading to a unique E-domain sequence with properties that diverge f ...
Are you struggling with extreme hair fall even after undergoing expensive treatments? Dermatologist explains why sometimes ...
Introduction In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency ...
Palazestrant’s mechanism of action confirmed; full recruitment of corepressor protein NCoR1 enables complete antagonism of the estrogen receptorOP-3136, in combination with palazestrant, exhibits ...
Atherosclerosis (AS) is a leading cause of mortality worldwide. AS is a progressive disease and so, early detection and ...
Recent AFCA decisions outline the requirements for formal and essential validity, explain how effectiveness is assessed and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results